Rituximab-Related Serious Infections Unlikely in Multiple Sclerosis
Serious infections related to treatment with rituximab in patients with multiple sclerosis are rare and successfully resolvable.
Serious infections related to treatment with rituximab in patients with multiple sclerosis are rare and successfully resolvable.